[HTML][HTML] Guidelines on the diagnosis and treatment of breast cancer (2011 edition)
…, J Chen, L Fu, XC Hu, ZF Jiang, HY Li, N Liao… - Gland …, 2012 - ncbi.nlm.nih.gov
… Bao-Ning Zhang, corresponding author Xu-Chen Cao, Jia-Yi Chen, Jie Chen, Li Fu, Xi-Chun
Hu, Ze-Fei Jiang, Hong-Yuan Li, Ning Liao, Dong-Geng Liu, Ouyang Tao, Zhi-Min Shao …
Hu, Ze-Fei Jiang, Hong-Yuan Li, Ning Liao, Dong-Geng Liu, Ouyang Tao, Zhi-Min Shao …
[HTML][HTML] A review of ULK1-mediated autophagy in drug resistance of cancer
L Liu, L Yan, N Liao, WQ Wu, JL Shi - Cancers, 2020 - mdpi.com
The difficulty of early diagnosis and the development of drug resistance are two major barriers
to the successful treatment of cancer. Autophagy plays a crucial role in several cellular …
to the successful treatment of cancer. Autophagy plays a crucial role in several cellular …
Flavonoids from Ziziphus jujuba Mill var. spinosa
…, Y Bai, Y Zhao, J Tao, Y Liu, G Tu, L Ma, N Liao… - Tetrahedron, 2000 - Elsevier
Eight flavonoid compounds were isolated from the seeds of Ziziphus jujuba Mill var. Spinosa.
On the basis of chemical and spectral analyses their structures were elucidated as swertish …
On the basis of chemical and spectral analyses their structures were elucidated as swertish …
Potential of lactic acid bacteria derived polysaccharides for the delivery and controlled release of oral probiotics
N Liao, B Pang, H Jin, X Xu, L Yan, H Li, D Shao… - Journal of controlled …, 2020 - Elsevier
Food and oral pharmaceutical products containing probiotics have tremendous health
benefits and have recently attracted a great amount of attention. However, the delivery and …
benefits and have recently attracted a great amount of attention. However, the delivery and …
Related searches
[HTML][HTML] Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status
…, X Chen, J Lin, G Wei, Y Li, Y Zhang, CM Balch, N Liao - BMC medicine, 2022 - Springer
Background HER2-low breast cancers were reported to have distinct clinicopathological
characteristics from HER2-zero; however, the difference in their genetic features remains …
characteristics from HER2-zero; however, the difference in their genetic features remains …
Efficacy, safety, and tolerability of pertuzumab, trastuzumab, and docetaxel for patients with early or locally advanced ERBB2-positive breast cancer in Asia: the …
…, D Pang, H Yang, W Li, S Wang, S Cui, N Liao… - JAMA …, 2020 - jamanetwork.com
Importance Prospective assessment of treatments known to benefit patients in global clinical
trials in specific racial groups is essential. Objective To compare the efficacy, safety, and …
trials in specific racial groups is essential. Objective To compare the efficacy, safety, and …
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2–advanced breast cancer: the multinational randomized phase III study
…, QC Ouyang, X Chen, N Liao… - … in medical oncology, 2020 - journals.sagepub.com
Aim: To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET)
versus ET alone in postmenopausal women with hormone receptor (HR)-positive, …
versus ET alone in postmenopausal women with hormone receptor (HR)-positive, …
Oligosaccharides as co-encapsulating agents: effect on oral Lactobacillus fermentum survival in a simulated gastrointestinal tract
N Liao, B Luo, J Gao, X Li, Z Zhao, Y Zhang, Y Ni… - Biotechnology …, 2019 - Springer
Objectives Four kinds of oligosaccharides were used as co-encapsulating agents to test the
effect of extrusion-based microencapsulation on protection of Lactobacillus fermentum L7 …
effect of extrusion-based microencapsulation on protection of Lactobacillus fermentum L7 …
Vitamin A supplementation ameliorates ulcerative colitis in gut microbiota–dependent manner
B Pang, H Jin, N Liao, J Li, C Jiang, J Shi - Food Research International, 2021 - Elsevier
Ulcerative colitis (UC), is a chronic relapsing inflammatory condition of the gastrointestinal
track. The purpose of this study is to explore whether Vitamin A (V A ) can treat UC and its …
track. The purpose of this study is to explore whether Vitamin A (V A ) can treat UC and its …
[HTML][HTML] JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer
B Chen, J Lai, D Dai, R Chen, X Li, N Liao - Aging (Albany NY), 2019 - ncbi.nlm.nih.gov
Clinical trials testing Janus kinase-1 (JAK1) inhibitors in cancers are under way. Whether the
JAK1 mRNA levels in breast tumors correlates with outcome has not been evaluated. JAK1 …
JAK1 mRNA levels in breast tumors correlates with outcome has not been evaluated. JAK1 …